DxVx Secures License for OVM-200 Anti-Cancer Vaccine from Oxford Vacmedix
South Korea-based DxVx is poised to license OVM-200 from Oxford Vacmedix (OVM), with plans to...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity
South Korea-based DxVx is poised to license OVM-200 from Oxford Vacmedix (OVM), with plans to...